The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2a trial of nadunolimab, a first-in-class fully humanized monoclonal antibody against IL1RAP, in combination with cisplatin and gemcitabine (CG) in patients with non-small cell lung cancer (NSCLC).
 
Astrid Paulus
Research Funding - Amgen
 
Saulius Cicenas
No Relationships to Disclose
 
Zanete Zvirbule
No Relationships to Disclose
 
Luis G. Paz-Ares
Leadership - ALTUM Sequencing; Genomica
Honoraria - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Hutchmed (I); Ipsen; Lilly; Merck Serono; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sanofi; Servier; Takeda
Speakers' Bureau - AstraZeneca; BMS; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); BMS (Inst); Kura Oncology (Inst); MSD (Inst); Pfizer (Inst); PharmaMar (Inst)
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
Ahmad Awada
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Eisai; Genomic Health; Ipsen; LEO Pharma; Lilly; Merck Serono; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
 
Ignacio Garcia-Ribas
Employment - Cantargia AB
Stock and Other Ownership Interests - Cantargia AB; Sanofi
Consulting or Advisory Role - Shionogi; TFS; Triact Therapeutics
 
Nedjad Losic
Employment - Cantargia AB
Leadership - Cantargia AB
Stock and Other Ownership Interests - Cantargia AB; Genmab
 
Marius Zemaitis
Consulting or Advisory Role - AstraZeneca/MedImmune; Janssen; MSD; Swixx BioPharma
Speakers' Bureau - AstraZeneca/MedImmune; Lilly; MSD; Roche; Swixx BioPharma